CA
BHC icon

Commerzbank Aktiengesellschaft’s Bausch Health BHC Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-46,947
Closed -$728K – 136
2020
Q1 		$728K Sell
46,947
-254,971
-84% -$6.15M 0.03% 216
2019
Q4 		$9.03M Sell
301,918
-738,872
-71% -$19.2M 0.09% 154
2019
Q3 		$22.7M Sell
1,040,790
-13,696
-1% -$313K 0.17% 108
2019
Q2 		$26.6M Buy
1,054,486
+272,702
+35% +$6.47M 0.21% 101
2019
Q1 		$19.3M Buy
781,784
+19,562
+3% +$467K 0.18% 110
2018
Q4 		$14.1M Buy
762,222
+21,077
+3% +$501K 0.14% 123
2018
Q3 		$19M Buy
741,145
+48,220
+7% +$1.1M 0.16% 112
2018
Q2 		$16.1M Sell
692,925
-100,759
-13% -$2.08M 0.15% 125
2018
Q1 		$12.6M Buy
793,684
+132,703
+20% +$2.47M 0.13% 152
2017
Q4 		$13.7M Sell
660,981
-170,007
-20% -$2.7M 0.16% 120
2017
Q3 		$11.9M Buy
830,988
+390,115
+88% +$5.9M 0.16% 129
2017
Q2 		$7.63M Buy
440,873
+260,881
+145% +$3.13M 0.13% 155
2017
Q1 		$1.99M Sell
179,992
-367,085
-67% -$5.05M 0.03% 354
2016
Q4 		$7.94M Buy
547,077
+334,814
+158% +$6.14M 0.12% 161
2016
Q3 		$5.21M Sell
212,263
-19,489
-8% -$504K 0.08% 203
2016
Q2 		$4.67K Buy
231,752
+30,207
+15% +$855K 0.03% 243
2016
Q1 		$5.3M Buy
201,545
+69,836
+53% +$5.16M 0.04% 230
2015
Q4 		$13.4M Buy
131,709
+31,398
+31% +$3.53M 0.1% 153
2015
Q3 		$17.9M Sell
100,311
-1,625
-2% -$379K 0.13% 120
2015
Q2 		$22.6M Buy
101,936
+2,279
+2% +$505K 0.12% 120
2015
Q1 		$19.8M Sell
99,657
-54,219
-35% -$9.62M 0.12% 127
2014
Q4 		$22M Buy
153,876
+32,251
+27% +$4.34M 0.14% 124
2014
Q3 		$16M Buy
121,625
+60,842
+100% +$7.25M 0.06% 222
2014
Q2 		$7.67M Buy
60,783
+28,525
+88% +$3.64M 0.04% 337
2014
Q1 		$4.25M Buy
32,258
+1,210
+4% +$165K 0.02% 503
2013
Q4 		$4.21M Buy
31,048
+26,166
+536% +$2.87M 0.02% 522
2013
Q3 		$509K Sell
4,882
-2,448
-33% -$238K ﹤0.01% 978
2013
Q2 		$631K Buy
+7,330
New +$578K ﹤0.01% 1009

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Commerzbank Aktiengesellschaft's BHC Position: Q2 2020 in Review

Commerzbank Aktiengesellschaft sold out of Bausch Health (BHC) in Q2 2020, closing a stake of 46,947 shares — an estimated $728K sold.

Commerzbank Aktiengesellschaft first reported a position in BHC in Q2 2013 and held it in 28 quarters. The position peaked at $26.6M in Q2 2019. 303 funds tracked by Wall St. Rank hold BHC as of Q2 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Bausch Health position as of Q2 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 46,947 Bausch Health shares in Q2 2020, an estimated $728K.
  • Commerzbank Aktiengesellschaft first reported a position in Bausch Health in Q2 2013 and held it in 28 quarters.
  • Commerzbank Aktiengesellschaft's Bausch Health position peaked at $26.6M in Q2 2019.
  • 303 funds tracked by Wall St. Rank held Bausch Health as of Q2 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2020, filed 21 Jul 2020.